Dr. SS. Iyengar
Non-HDL Cholesterol
- ASCVD risk remains high in patients who have attained the guideline – recommended LDL-C goals.
- In some circumstances like diabetes, obesity or very low LDL-C, it may underestimate the risk conferred by other apoB-containing lipoproteins.
- In these conditions, the simple calculation of non-HDL-C captures all apoB-containing lipoproteins, including remnant cholesterol.
- LAI recommendations-2020
- Non-HDL-C is a co-primary target
- Elevated apoB is a moderate nonconventional risk factor (a level >110 mg/dL of apoB corresponds to an LDL-C >130 mg/dL).
LDL
Cholesterol
Has
Limitation Overall
Non-HDL-C
Is The First
Choice You See
For Now, ApoB
Has To Stay
As Option B!
Dr. SS. Iyengar
Dr. SS. Iyengar is a currently associated with Manipal Hospital (Bangalore) is an Interventional Cardiologist who values shared medical decision-making and believes that input from patients and families is as vital to the process as physician input is. He specializes in the prevention, diagnosis and interventional treatment of diseases of the heart and blood vessels such as acute heart attack, heart failure, arthymia, rhythm disturbance, valvoplasty.Having done his MBBS, MD(Medicine),DM(Cardiology) from Pune University,he further went to do his fellowship from Royal College Of Physicians (U.K).
More FAQs by Dr. SS. Iyengar
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article